Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | CWF19L2 | Human | 1,2-dichloroethane | decreases expression | ISO | Cwf19l2 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of CWF19L2 mRNA | CTD | PMID:28960355 | CWF19L2 | Human | 1,2-dimethylhydrazine | decreases expression | ISO | Cwf19l2 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of CWF19L2 mRNA | CTD | PMID:22206623 | CWF19L2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Cwf19l2 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CWF19L2 mRNA | CTD | PMID:21215274 | CWF19L2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Cwf19l2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CWF19L2 mRNA | CTD | PMID:21570461 and PMID:26377647 | CWF19L2 | Human | 2-hydroxypropanoic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of CWF19L2 mRNA | CTD | PMID:30851411 | CWF19L2 | Human | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Cwf19l2 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of CWF19L2 mRNA | CTD | PMID:26251327 | CWF19L2 | Human | antirheumatic drug | increases expression | EXP | | 6480464 | Antirheumatic Agents results in increased expression of CWF19L2 mRNA | CTD | PMID:24449571 | CWF19L2 | Human | aristolochic acid A | decreases expression | EXP | | 6480464 | aristolochic acid I results in decreased expression of CWF19L2 mRNA | CTD | PMID:33212167 | CWF19L2 | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of CWF19L2 promoter | CTD | PMID:27901495 | CWF19L2 | Human | bisphenol A | decreases expression | ISO | Cwf19l2 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of CWF19L2 mRNA | CTD | PMID:33221593 | CWF19L2 | Human | bisphenol A | increases expression | ISO | Cwf19l2 (Mus musculus) | 6480464 | bisphenol A results in increased expression of CWF19L2 mRNA | CTD | PMID:35598803 | CWF19L2 | Human | bisphenol A | decreases expression | ISO | Cwf19l2 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of CWF19L2 mRNA | CTD | PMID:34947998 | CWF19L2 | Human | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of CWF19L2 mRNA | CTD | PMID:38568856 | CWF19L2 | Human | caffeine | decreases phosphorylation | EXP | | 6480464 | Caffeine results in decreased phosphorylation of CWF19L2 protein | CTD | PMID:35688186 | CWF19L2 | Human | chloroprene | increases expression | ISO | Cwf19l2 (Rattus norvegicus) | 6480464 | Chloroprene results in increased expression of CWF19L2 mRNA | CTD | PMID:23125180 | CWF19L2 | Human | chlorpyrifos | decreases expression | ISO | Cwf19l2 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of CWF19L2 mRNA | CTD | PMID:37019170 | CWF19L2 | Human | cocaine | increases expression | ISO | Cwf19l2 (Rattus norvegicus) | 6480464 | Cocaine results in increased expression of CWF19L2 mRNA | CTD | PMID:17898221 | CWF19L2 | Human | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of CWF19L2 mRNA | CTD | PMID:25562108 | CWF19L2 | Human | deoxynivalenol | increases expression | EXP | | 6480464 | deoxynivalenol results in increased expression of CWF19L2 mRNA | CTD | PMID:31863870 | CWF19L2 | Human | diazinon | affects expression | ISO | Cwf19l2 (Rattus norvegicus) | 6480464 | Diazinon affects the expression of CWF19L2 mRNA | CTD | PMID:22546817 | CWF19L2 | Human | dicrotophos | decreases expression | EXP | | 6480464 | dicrotophos results in decreased expression of CWF19L2 mRNA | CTD | PMID:28302478 | CWF19L2 | Human | dieldrin | affects expression | ISO | Cwf19l2 (Rattus norvegicus) | 6480464 | Dieldrin affects the expression of CWF19L2 mRNA | CTD | PMID:22546817 | CWF19L2 | Human | dioxygen | increases expression | ISO | Cwf19l2 (Mus musculus) | 6480464 | Oxygen deficiency results in increased expression of CWF19L2 mRNA | CTD | PMID:24205000 | CWF19L2 | Human | epoxiconazole | increases expression | ISO | Cwf19l2 (Mus musculus) | 6480464 | epoxiconazole results in increased expression of CWF19L2 mRNA | CTD | PMID:35436446 | CWF19L2 | Human | FR900359 | decreases phosphorylation | EXP | | 6480464 | FR900359 results in decreased phosphorylation of CWF19L2 protein | CTD | PMID:37730182 | CWF19L2 | Human | hydrogen peroxide | decreases expression | EXP | | 6480464 | Hydrogen Peroxide results in decreased expression of CWF19L2 mRNA | CTD | PMID:18951874 | CWF19L2 | Human | methidathion | decreases expression | ISO | Cwf19l2 (Mus musculus) | 6480464 | methidathion results in decreased expression of CWF19L2 mRNA | CTD | PMID:34813904 | CWF19L2 | Human | methoxychlor | affects methylation | ISO | Cwf19l2 (Rattus norvegicus) | 6480464 | Methoxychlor affects the methylation of CWF19L2 gene | CTD | PMID:35440735 | CWF19L2 | Human | methyl methanesulfonate | increases expression | EXP | | 6480464 | Methyl Methanesulfonate results in increased expression of CWF19L2 mRNA | CTD | PMID:23649840 | CWF19L2 | Human | miconazole | decreases expression | ISO | Cwf19l2 (Mus musculus) | 6480464 | Miconazole results in decreased expression of CWF19L2 mRNA | CTD | PMID:27462272 | CWF19L2 | Human | nickel dichloride | affects expression | ISO | Cwf19l2 (Rattus norvegicus) | 6480464 | nickel chloride affects the expression of CWF19L2 mRNA | CTD | PMID:22546817 | CWF19L2 | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Cwf19l2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of CWF19L2 mRNA | CTD | PMID:36331819 | CWF19L2 | Human | phenobarbital | increases expression | ISO | Cwf19l2 (Mus musculus) | 6480464 | Phenobarbital results in increased expression of CWF19L2 mRNA | CTD | PMID:19270015 | CWF19L2 | Human | potassium dichromate | increases expression | ISO | Cwf19l2 (Mus musculus) | 6480464 | Potassium Dichromate results in increased expression of CWF19L2 mRNA | CTD | PMID:23608068 | CWF19L2 | Human | rac-lactic acid | decreases expression | EXP | | 6480464 | Lactic Acid results in decreased expression of CWF19L2 mRNA | CTD | PMID:30851411 | CWF19L2 | Human | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of CWF19L2 mRNA | CTD | PMID:23557933 | CWF19L2 | Human | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of CWF19L2 mRNA | CTD | PMID:38568856 | CWF19L2 | Human | sodium arsenite | decreases expression | ISO | Cwf19l2 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of CWF19L2 mRNA | CTD | PMID:36209798 | CWF19L2 | Human | tacrine | increases expression | ISO | Cwf19l2 (Rattus norvegicus) | 6480464 | Tacrine results in increased expression of CWF19L2 mRNA | CTD | PMID:12832660 | CWF19L2 | Human | temozolomide | increases expression | EXP | | 6480464 | Temozolomide results in increased expression of CWF19L2 mRNA | CTD | PMID:31758290 | CWF19L2 | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of CWF19L2 mRNA | CTD | PMID:37042841 | CWF19L2 | Human | tungsten | decreases expression | ISO | Cwf19l2 (Mus musculus) | 6480464 | Tungsten results in decreased expression of CWF19L2 mRNA | CTD | PMID:30912803 | CWF19L2 | Human | urethane | decreases expression | EXP | | 6480464 | Urethane results in decreased expression of CWF19L2 mRNA | CTD | PMID:28818685 | CWF19L2 | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of CWF19L2 mRNA | CTD | PMID:25979313 | CWF19L2 | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of CWF19L2 mRNA | CTD | PMID:23179753 more ... | |